Description
Heparin anticoagulation to improve outcomes in septic shock: The HALO International Phase II Trial
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02017-04-01$631,125
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2017-04-01(start date) | $631,125 | — | Heparin anticoagulation to improve outcomes in septic shock: The HALO International Phase II Trial |
Related records · 6
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2026-2027-Q1-01257 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $2,648,253 | FY2027 |
| 236-2024-2025-Q1-00967 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $5,500,001 | FY2025 |
| 236-2024-2025-Q1-00805 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $1,375,000 | FY2025 |
| 236-2022-2023-Q3-00291 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $3,961,936 | FY2023 |
| 236-2020-2021-Q1-00776 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $3,573,336 | FY2021 |
| 236-2019-2020-Q2-00237 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $2,393,115 | FY2020 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2017-2018-Q1-00464 · retrieved 2026-11-13.